Alzheimer disease is evolving—and early action in primary care is more important than ever. This curriculum features four 15-minute microlearning activities and a 1-hour live virtual session to help you detect mild cognitive impairment, apply updated diagnostic criteria, and understand the role of blood-based biomarkers. You'll also explore which patients are most likely to benefit from anti-amyloid therapies. Gain practical tools to confidently navigate the latest in Alzheimer diagnosis and treatment.